WallStreetZenWallStreetZen

NASDAQ: ALT
Altimmune Inc Stock Ownership - Who owns Altimmune?

Open Broker Account

Insider buying vs selling

Have Altimmune Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Vipin K. GargPresident and CEO2022-08-3120,000$20.02
$400.32kSell
Vipin K. GargPresident and CEO2022-08-303,007$18.94
$56.95kSell
Vipin K. GargPresident and CEO2022-08-1215,000$15.06
$225.89kSell
M. Scot RobertsChief Scientific Officer2022-07-31732$6.86
$5.02kBuy
Richard I. EisenstadtChief Financial Officer2022-07-311,366$6.86
$9.37kBuy
Matthew Scott HarrisChief Medical Officer2022-07-311,076$6.86
$7.38kBuy
Vipin K. GargPresident and CEO2022-07-303,007$12.01
$36.11kSell
M. Scot RobertsChief Scientific Officer2022-07-05787$2.95
$2.32kBuy
M. Scot RobertsChief Scientific Officer2022-07-0510,182$12.00
$122.18kSell
M. Scot RobertsChief Scientific Officer2022-07-014,019$2.60
$10.45kBuy

1 of 5

ALT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALT insiders and whales buy or sell their stock.

ALT Shareholders

What type of owners hold Altimmune Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Prescott Group Capital Management LLC40.87%19,837,273$245.39MInsider
Novartis Bioventures Ltd17.19%8,345,145$103.23MInsider
Luke Evnin13.08%6,347,614$78.52MInsider
Mpm Bioventures Iii LLC13.08%6,347,614$78.52MInsider
Healthcare Ventures Vii LP9.02%4,378,057$54.16MInsider
Tang Capital Management LLC7.42%3,600,450$44.54MInstitution
Venrock Healthcare Capital Partners Iii LP7.21%3,500,000$43.30MInsider
James H. Cavanaugh6.83%3,317,243$41.03MInsider
Nuveen Asset Management LLC6.31%3,064,280$37.91MInstitution
Cormorant Asset Management LP6.18%3,000,000$37.11MInstitution

1 of 3

ALT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALT38.74%61.26%Net SellingNet Selling
GHRS62.55%0.00%
VRDN50.07%49.93%Net BuyingNet Buying
INBX62.47%37.53%Net SellingNet Selling
NKTR95.84%4.16%Net SellingNet Selling

Altimmune Stock Ownership FAQ

Who owns Altimmune?

Altimmune (NASDAQ: ALT) is owned by 81.84% institutional shareholders, 129.44% Altimmune insiders, and 0.00% retail investors. Prescott Group Capital Management LLC is the largest individual Altimmune shareholder, owning 19.84M shares representing 40.87% of the company. Prescott Group Capital Management LLC's Altimmune shares are currently valued at $232.69M.

If you're new to stock investing, here's how to buy Altimmune stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.